期刊文献+

扩张型心肌病左心结构功能心脏磁共振评价与NT-proBNP相关性研究 被引量:13

Evaluation of left ventricular function by cardiac magnetic imaging in dilated cardiomyopathy and the relationship with plasma NT-proBNP levels
下载PDF
导出
摘要 目的 :扩张型心肌病(Dilated cardiomyopathy,DCM)主要引起左心室扩大和功能障碍,具有较高的发病率和死亡率。本研究通过心脏磁共振(CMR)电影评价DCM患者左心室结构功能,并探讨其与血浆NT-proBNP水平的相关性。方法:经完整临床资料诊断为扩张型心肌病的患者22例纳入研究,所有患者接受CMR电影检查及血浆NT-proBNP水平检测。CMR扫描数据导入后处理软件cardiac explorer获得左心室结构功能参数值,包括左心室舒张末期容积(LVEDV)、左心室收缩末期容积(LVESV)、左心室射血分数(LVEF)、每搏输出量(SV)、心输出量(CO)、心指数(CI)、左室心肌质量(LVMM)、短轴缩短率(FS)、左心室舒张末期内径(LVEDD)、球形指数(SI)。上述左心室结构功能参数值与血浆NT-proBNP水平行相关性分析。结果:血浆NT-proBNP水平与LVEDV(r=0.596,P=0.003)、LVESV(r=0.742,P=0.000)、LVMM(r=0.763,P=0.000)、LVEDD(r=0.629,P=0.002)呈正相关关系,与LVEF(r=-0.829,P=0.000)、FS(r=-0.623,P=0.002)、SI(r=-0.539,P=0.010)呈负相关关系,其中与LVEF相关性最高。结论:CMR可以很好反映DCM左室重构后结构与功能的改变,DCM患者左心室腔扩大越明显、心肌质量增加越重,血浆NT-proBNP水平越高,提示血浆NT-proBNP水平与心室重构的严重程度相关。 Objective: Dilated cardiomyopathy(DCM) is characterized with left ventricular dilatation and dysfunction, which has a high morbidity and mortality. Our study is to investigate relationship between the left ventricular function by cardiac magenetic imaging(CMR) and plasma NT-proBNP levels in DCM. Methods: Twenty-two cases of DCM were enrolled. All patients received CMR examination and NT-proBNP level test. The imaging data of CMR were transferred to cardiac explorer workstation and the parameters of left ventricular structure and function were calculated. The parameters included LVEDV,LVESV, LVEF, SV, CO, CI, LVMM, FS, LVEDD, and SI. The correlation between all the parameters and plasma NT-proBNP levels was analyzed. Result: The plasma NT-proBNP levels in patients with DCM had a linear correlation with LVEDV,LVESV, LVEF, LVMM, FS, LVEDD and SI. The plasma NT-proBNP levels showed a positive correlation with LVEDV(r =0.596, P=0.003), LVESV(r=0.742, P=0.000), LVMM(r=0.763, P=0.000) and LVEDD(r=0.629, P=0.002) and negative correlation with LVEF(r=-0.829, P=0.000), FS(r=-0.623, P=0.002) and SI(r=-0.539, P=0.010). The coefficient of correlation between plasma NT-proBNP levels and LVEF was the highest. Conclusion: CMR can provide more valuable information for left ventricular remodeling and function in DCM patients. The more dilatation of the left ventricular chamber, the worse the cardiac function,the heavier the myocardial burden, and the higher the plasma NT-proBNP levels are. It demonstrates that the plasma NT-proBNP levels can reflect the severity of cardiac structure and function, and further reflect the severity of ventricular remodeling.
作者 张颖雪 赵新湘 ZHANG Ying-xue;ZHAO Xin-xiang(Department of Radiology, Nanyang Central Hospital, Nanyang Henan 473000, China;Department of Radiology, the 2nd Affiliated Hospital of Kunming Medical University, Kanming 650101, China)
出处 《中国临床医学影像杂志》 CAS 2018年第6期404-408,共5页 Journal of China Clinic Medical Imaging
基金 云南省中青年学术技术带头人培养项目(2015HB06) 云南省医学学科带头人培养项目(D-201646) 云南省联合专项重点项目(2017FE468-178) 云南省高校科技创新团队支持计划资助
关键词 心肌病 扩张型 心室功能 磁共振成像 Cardiomyopathy dilated Ventricular function left Magnetic resonance imaging
  • 相关文献

参考文献3

二级参考文献89

  • 1程流泉,高元桂,盛复庚,蔡幼铨.磁共振心脏成像平面的定位与解剖[J].中国医学影像学杂志,2004,12(5):321-324. 被引量:11
  • 2王志民,邹玉宝,宋雷,马爱群,刘唐威,谷惠敏,卢赛兰,武鹏翥,孙兆明,何国宝,张卫,张颖,沈丽,蔡玉岭,甄一松,刘延玲,惠汝太.超声心动图检查调查8080例成人肥厚型心肌病患病率[J].中华心血管病杂志,2004,32(12):1090-1094. 被引量:59
  • 3张寄南,曹克将.肥厚型心肌病诊断与治疗——美国心脏病学学会/欧洲心脏病学学会、美国心脏病协会专家共识导读[J].中华心血管病杂志,2005,33(6):491-494. 被引量:35
  • 4廖玉华,袁璟.扩张型心肌病分子免疫治疗靶点的研究进展[J].中华医学杂志,2006,86(17):1158-1160. 被引量:8
  • 5杨华,张小明,赵建农,曾南林.2D-FIESTA MRI对左心室壁功能的评价[J].中国医学计算机成像杂志,2006,12(6):379-383. 被引量:3
  • 6Richardson P,McKenna W,Bristow M,et al.Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.Circulation,1996,93(5):841-842.
  • 7Maron BJ,Towbin JA,Thiene G,et al.Contemporary definitions and classification of the cardiomyopathies:an American Heart Association Scientific Statement from the Council on Clinical Cardiology,Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.Circulation,2006,113(14):1807-1816.
  • 8Elliott PM,Mckenna WJ.Natural history of hypertrophic cardiomyopathy.[EB/OL][2006-8-2].http://www.utdol.com/utd/content/topic.do?topicKey=myoperic/11502&type=A&selectedTitle=4~58.
  • 9Cooper LT.Definition and classification of the cardiomyopathies.[EB/OL][2006-8-2].http://www.utdol.com.beckerproxy.wustl.edu/applica.../6085&type=A&selectedTitle=2~5.
  • 10McKenna WJ.Genetics of hypertrophic cardiomyopathy.[EB/OL][2006-8-2].http://www.utdol.com/utd/content/topic.do?topicKey=myoperic/9673&type=A&selectedTitle=3~58.

共引文献559

同被引文献104

引证文献13

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部